Immunohistochemistry for HER2 shows positive membrane staining in this infiltrating ductal carcinoma.

Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain

ROCHESTER, Minn. — Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a…

No information found.

Sign up